Physician profile
Loretta Mcatee
NPI 1295562577
$1,301.01
in general payments reported to CMS, 2019-2025
17 companies · $1,046 in 2025
The $1,046 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $255 · 2025: $1,046.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,292 · Education: $9.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,292.01 |
| Education | $9.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $256.64 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Medtronic, INC. | $154.19 | 2024-2025 | Linq II, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $113.01 | 2024-2025 | Assurity, Gallant, Aveir |
| Astrazeneca Pharmaceuticals LP | $100.59 | 2024-2025 | Wainua, Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $95.48 | 2024-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.06 | 2025 | Jardiance |
| Amgen INC. | $83.65 | 2024-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $70.44 | 2025 | Verquvo, Capvaxive |
| Pfizer INC. | $59.87 | 2025 | |
| Bridgebio Pharma, INC. | $51.84 | 2025 | Attruby |
| Tactile Systems Technology INC | $50.68 | 2025 | Nimbl, Flexitouch Plus |
| Esperion Therapeutics, INC. | $48.60 | 2025 | Nexletol |
| Abiomed | $45.89 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $23.77 | 2025 | Camzyos |
| Regeneron Healthcare Solutions, INC. | $21.29 | 2025 | Evkeeza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $19.31 | 2025 | |
| Chiesi USA, INC. | $14.70 | 2025 | Juxtapid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loretta Mcatee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.